A Systematic Review and Meta-Analysis: Safety and Efficacy of Cediranib in the Treatment of Cancer Patients

Figure 2

(a) Risk of bias graph: review authors’ judgments on each risk of bias item presented as percentages across all included studies. (b) Risk of bias summary: review authors’ judgments on each risk of bias item for each included study. (c) Certainty of evidence for major outcomes.

(a)

(b)

(c)